{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T03:12:42Z","timestamp":1773198762735,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.clinthera.2017.03.015","type":"journal-article","created":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T18:01:01Z","timestamp":1492624861000},"page":"960-970","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Analysis of 2-Week Data from Two Randomized, Controlled Trials Conducted in Subjects with Frequent Heartburn Treated with Esomeprazole 20 mg"],"prefix":"10.1016","volume":"39","author":[{"given":"Philip O.","family":"Katz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Le Moigne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Pollack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2017.03.015_bib1","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1365-2036.2010.04564.x","article-title":"A 13-nation population survey of upper gastrointestinal symptoms: prevalence of symptoms and socioeconomic factors","volume":"33","author":"Haag","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2017.03.015_bib2","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/gutjnl-2012-304269","article-title":"Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review","volume":"63","author":"El-Serag","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.clinthera.2017.03.015_bib3","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1136\/gutjnl-2011-300715","article-title":"Changes in prevalence, incidence and spontaneous loss of gastro-oesophageal reflux symptoms: a prospective population-based cohort study, the HUNT study","volume":"61","author":"Ness-Jensen","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.clinthera.2017.03.015_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cgh.2006.09.016","article-title":"Time trends of gastroesophageal reflux disease: a systematic review","volume":"5","author":"El-Serag","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2017.03.015_bib5","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000235953","article-title":"Management of reflux symptoms with over-the-counter proton pump inhibitors: issues and proposed guidelines","volume":"80","author":"Haag","year":"2009","journal-title":"Digestion"},{"key":"10.1016\/j.clinthera.2017.03.015_bib6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1542-3565(05)00153-9","article-title":"Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study","volume":"3","author":"Camilleri","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2017.03.015_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archinte.161.1.45","article-title":"The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life","volume":"161","author":"Farup","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2017.03.015_bib8","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/j.1572-0241.2003.07531.x","article-title":"Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association","volume":"98","author":"Shaker","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinthera.2017.03.015_bib9","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1053\/j.gastro.2012.08.002","article-title":"Burden of gastrointestinal disease in the United States: 2012 update","volume":"143","author":"Peery","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2017.03.015_bib10","first-page":"CD002095","article-title":"Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease","author":"van Pinxteren","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinthera.2017.03.015_bib11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/MEG.0b013e3282f2a5bd","article-title":"Healthcare seeking in gastro-oesophageal reflux disease: a qualitative study","volume":"20","author":"Jones","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2017.03.015_bib12","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1345\/aph.1L647","article-title":"Self-medication of upper gastrointestinal symptoms: a community pharmacy study","volume":"43","author":"Mehuys","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2017.03.015_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1542-3565(03)00287-8","article-title":"Self-selection and use patterns of over-the-counter omeprazole for frequent heartburn","volume":"2","author":"Fendrick","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2017.03.015_bib14","series-title":"Nexium 24HR (esomeprazole) [product labeling]","year":"2014"},{"key":"10.1016\/j.clinthera.2017.03.015_bib15","series-title":"Nexium Control (esomeprazole) [summary of product characteristics]","year":"2014"},{"key":"10.1016\/j.clinthera.2017.03.015_bib16","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1046\/j.1365-2036.2003.01771.x","article-title":"Esomeprazole resolves chronic heartburn in patients without erosive oesophagitis","volume":"18","author":"Katz","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2017.03.015_bib17","series-title":"Nexium (esomeprazole) [package insert]","year":"2014"},{"key":"10.1016\/j.clinthera.2017.03.015_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3810\/pgm.2014.07.2781","article-title":"Esomeprazole treatment of frequent heartburn: two randomized, double-blind, placebo-controlled trials","volume":"126","author":"Peura","year":"2014","journal-title":"Postgrad Med"},{"key":"10.1016\/j.clinthera.2017.03.015_bib19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2710.2004.00620.x","article-title":"Comparison of Prilosec OTC (omeprazole magnesium 20.6 mg) to placebo for 14 days in the treatment of frequent heartburn","volume":"30","author":"Allgood","year":"2005","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.clinthera.2017.03.015_bib20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3810\/pgm.2009.07.2019","article-title":"Lansoprazole 15 mg once daily for 14 days is effective for treatment of frequent heartburn: results of 2 randomized, placebo-controlled, double-blind studies","volume":"121","author":"Kushner","year":"2009","journal-title":"Postgrad Med"},{"key":"10.1016\/j.clinthera.2017.03.015_bib21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1155\/2012\/235476","article-title":"Patient satisfaction with medication for gastroesophageal reflux disease: a systematic review","volume":"26","author":"van Zanten","year":"2012","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.clinthera.2017.03.015_bib22","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1046\/j.1365-2036.2003.01770.x","article-title":"Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative","volume":"18","author":"Kulig","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2017.03.015_bib23","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.cgh.2008.11.021","article-title":"A systematic review of the definitions, prevalence, and response to treatment of nocturnal gastroesophageal reflux disease","volume":"7","author":"Gerson","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2017.03.015_bib24","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.cgh.2009.04.005","article-title":"Effects of gastroesophageal reflux disease on sleep and outcomes","volume":"7","author":"Mody","year":"2009","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291817301972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291817301972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T15:53:41Z","timestamp":1535903621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291817301972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0149291817301972"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2017.03.015","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of 2-Week Data from Two Randomized, Controlled Trials Conducted in Subjects with Frequent Heartburn Treated with Esomeprazole 20 mg","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2017.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}